Literature DB >> 18482482

Recent advances in the treatment of age-related macular degeneration.

Ameenat Lola Solebo, Romesh I Angunawela, Samipa Dasgupta, John Marshall.   

Abstract

Mesh：

Year:  2008        PMID： 18482482      PMCID： PMC2435664          DOI： 10.3399/096016408784217395

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  13 in total

Review 1.  Age-related macular degeneration and depression: a review of recent research.

Authors:  Robin J Casten; Barry W Rovner; William Tasman
Journal:  Curr Opin Ophthalmol       Date:  2004-06       Impact factor: 3.761

2.  The epidemiology, economics and quality of life burden of age-related macular degeneration in France, Germany, Italy and the United Kingdom.

Authors:  J Bonastre; C Le Pen; P Anderson; A Ganz; P Berto; G Berdeaux
Journal:  Eur J Health Econ       Date:  2002

3.  Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration.

Authors:  Jason S Slakter; Thomas W Bochow; Donald J D'Amico; Bethany Marks; Janice Jerdan; E Kenneth Sullivan; Stella M Robertson; Jason S Slakter; Greg Sullins; Patricia Zilliox
Journal:  Ophthalmology       Date:  2005-12-20       Impact factor: 12.079

Review 4.  Squalamine lactate for exudative age-related macular degeneration.

Authors:  Brian Connolly; Avinash Desai; Charles A Garcia; Edgar Thomas; Michael J Gast
Journal:  Ophthalmol Clin North Am       Date:  2006-09

5.  Ranibizumab for neovascular age-related macular degeneration.

Authors:  Philip J Rosenfeld; David M Brown; Jeffrey S Heier; David S Boyer; Peter K Kaiser; Carol Y Chung; Robert Y Kim
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

6.  A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration.

Authors:  Zhenglin Yang; Nicola J Camp; Hui Sun; Zongzhong Tong; Daniel Gibbs; D Joshua Cameron; Haoyu Chen; Yu Zhao; Erik Pearson; Xi Li; Jeremy Chien; Andrew Dewan; Jennifer Harmon; Paul S Bernstein; Viji Shridhar; Norman A Zabriskie; Josephine Hoh; Kimberly Howes; Kang Zhang
Journal:  Science       Date:  2006-10-19       Impact factor: 47.728

7.  Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.

Authors:  Eva Lonn; Jackie Bosch; Salim Yusuf; Patrick Sheridan; Janice Pogue; J Malcolm O Arnold; Catherine Ross; Andrew Arnold; Peter Sleight; Jeffrey Probstfield; Gilles R Dagenais
Journal:  JAMA       Date:  2005-03-16       Impact factor: 56.272

8.  A value-based medicine comparison of interventions for subfoveal neovascular macular degeneration.

Authors:  Gary C Brown; Melissa M Brown; Heidi C Brown; Sylvia Kindermann; Sanjay Sharma
Journal:  Ophthalmology       Date:  2007-02-23       Impact factor: 12.079

Review 9.  Pegaptanib sodium for the treatment of neovascular age-related macular degeneration: a review.

Authors:  Helen Kourlas; Daryl S Schiller
Journal:  Clin Ther       Date:  2006-01       Impact factor: 3.393

10.  Risk factors for incident age-related macular degeneration: pooled findings from 3 continents.

Authors:  Sandra C Tomany; Jie Jin Wang; Redmer Van Leeuwen; Ronald Klein; Paul Mitchell; Johannes R Vingerling; Barbara E K Klein; Wayne Smith; Paulus T V M De Jong
Journal:  Ophthalmology       Date:  2004-07       Impact factor: 12.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.